Annual Net Income
-$113.72 M
+$136.43 M+54.54%
December 31, 2023
Summary
- As of February 12, 2025, MCRB annual net profit is -$113.72 million, with the most recent change of +$136.43 million (+54.54%) on December 31, 2023.
- During the last 3 years, MCRB annual net income has fallen by -$24.60 million (-27.60%).
- MCRB annual net income is now -3538.00% below its all-time high of -$3.13 million, reached on December 31, 2012.
Performance
MCRB Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
$88.78 M
+$121.65 M+370.08%
September 30, 2024
Summary
- As of February 12, 2025, MCRB quarterly net profit is $88.78 million, with the most recent change of +$121.65 million (+370.08%) on September 30, 2024.
- Over the past year, MCRB quarterly net income has increased by +$130.02 million (+315.22%).
- MCRB quarterly net income is now at all-time high.
Performance
MCRB Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$25.48 M
+$136.63 M+84.28%
September 30, 2024
Summary
- As of February 12, 2025, MCRB TTM net profit is -$25.48 million, with the most recent change of +$136.63 million (+84.28%) on September 30, 2024.
- Over the past year, MCRB TTM net income has increased by +$88.25 million (+77.60%).
- MCRB TTM net income is now -1408.29% below its all-time high of -$1.69 million, reached on March 31, 2014.
Performance
MCRB TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
MCRB Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +54.5% | +315.2% | +77.6% |
| 3 y3 years | -27.6% | +229.0% | +89.8% |
| 5 y5 years | -14.9% | +229.0% | +89.8% |
MCRB Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -73.4% | +54.5% | at high | +224.7% | at high | +90.4% |
| 5 y | 5-year | -73.4% | +54.5% | at high | +224.7% | at high | +90.4% |
| alltime | all time | -3538.0% | +54.5% | at high | +224.7% | -1408.3% | +90.4% |
Seres Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $88.78 M(-370.1%) | -$25.48 M(-84.3%) |
| Jun 2024 | - | -$32.87 M(-18.1%) | -$162.10 M(+96.1%) |
| Mar 2024 | - | -$40.13 M(-2.7%) | -$82.68 M(-27.3%) |
| Dec 2023 | -$113.72 M(-54.5%) | -$41.25 M(-13.8%) | -$113.72 M(-19.5%) |
| Sep 2023 | - | -$47.85 M(-202.8%) | -$141.27 M(-7.9%) |
| Jun 2023 | - | $46.55 M(-165.4%) | -$153.42 M(-42.0%) |
| Mar 2023 | - | -$71.17 M(+3.5%) | -$264.71 M(+5.8%) |
| Dec 2022 | -$250.16 M(+281.5%) | -$68.80 M(+14.7%) | -$250.16 M(+8.1%) |
| Sep 2022 | - | -$60.00 M(-7.3%) | -$231.36 M(+124.3%) |
| Jun 2022 | - | -$64.73 M(+14.3%) | -$103.14 M(+18.9%) |
| Mar 2022 | - | -$56.62 M(+13.2%) | -$86.74 M(+32.3%) |
| Dec 2021 | -$65.58 M(-26.4%) | -$50.00 M(-173.3%) | -$65.58 M(+93.9%) |
| Sep 2021 | - | $68.22 M(-241.2%) | -$33.83 M(-74.4%) |
| Jun 2021 | - | -$48.33 M(+36.3%) | -$132.33 M(+26.4%) |
| Mar 2021 | - | -$35.47 M(+94.3%) | -$104.71 M(+17.5%) |
| Dec 2020 | -$89.13 M(+26.8%) | -$18.25 M(-39.7%) | -$89.13 M(-0.6%) |
| Sep 2020 | - | -$30.28 M(+46.2%) | -$89.65 M(+18.3%) |
| Jun 2020 | - | -$20.71 M(+4.2%) | -$75.78 M(+15.1%) |
| Mar 2020 | - | -$19.88 M(+5.9%) | -$65.83 M(-6.3%) |
| Dec 2019 | -$70.28 M | -$18.78 M(+14.4%) | -$70.28 M(-3.4%) |
| Sep 2019 | - | -$16.41 M(+52.5%) | -$72.79 M(-7.1%) |
| Jun 2019 | - | -$10.76 M(-55.8%) | -$78.33 M(-17.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$24.33 M(+14.3%) | -$95.36 M(-3.6%) |
| Dec 2018 | -$98.94 M(+10.7%) | -$21.29 M(-3.0%) | -$98.94 M(-7.2%) |
| Sep 2018 | - | -$21.95 M(-21.0%) | -$106.61 M(+16.4%) |
| Jun 2018 | - | -$27.79 M(-0.5%) | -$91.59 M(-0.3%) |
| Mar 2018 | - | -$27.92 M(-3.6%) | -$91.83 M(+2.7%) |
| Dec 2017 | -$89.38 M(-2.4%) | -$28.95 M(+317.5%) | -$89.38 M(+4.3%) |
| Sep 2017 | - | -$6.93 M(-75.2%) | -$85.70 M(-12.1%) |
| Jun 2017 | - | -$28.02 M(+10.0%) | -$97.46 M(+0.1%) |
| Mar 2017 | - | -$25.47 M(+0.8%) | -$97.35 M(+6.3%) |
| Dec 2016 | -$91.58 M(+67.2%) | -$25.28 M(+35.3%) | -$91.58 M(+6.6%) |
| Sep 2016 | - | -$18.69 M(-33.0%) | -$85.94 M(+5.0%) |
| Jun 2016 | - | -$27.91 M(+41.7%) | -$81.87 M(+23.1%) |
| Mar 2016 | - | -$19.70 M(+0.4%) | -$66.51 M(+21.4%) |
| Dec 2015 | -$54.78 M(+227.8%) | -$19.63 M(+34.3%) | -$54.78 M(+26.4%) |
| Sep 2015 | - | -$14.62 M(+16.4%) | -$43.33 M(+31.8%) |
| Jun 2015 | - | -$12.55 M(+57.5%) | -$32.87 M(+43.0%) |
| Mar 2015 | - | -$7.97 M(-2.6%) | -$22.99 M(+37.6%) |
| Dec 2014 | -$16.71 M(+173.8%) | -$8.18 M(+96.6%) | -$16.71 M(+96.0%) |
| Sep 2014 | - | -$4.16 M(+55.4%) | -$8.53 M(+95.3%) |
| Jun 2014 | - | -$2.68 M(+58.5%) | -$4.37 M(+158.5%) |
| Mar 2014 | - | -$1.69 M | -$1.69 M |
| Dec 2013 | -$6.10 M(+95.2%) | - | - |
| Dec 2012 | -$3.13 M | - | - |
FAQ
- What is Seres Therapeutics annual net profit?
- What is the all time high annual net income for Seres Therapeutics?
- What is Seres Therapeutics annual net income year-on-year change?
- What is Seres Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Seres Therapeutics?
- What is Seres Therapeutics quarterly net income year-on-year change?
- What is Seres Therapeutics TTM net profit?
- What is the all time high TTM net income for Seres Therapeutics?
- What is Seres Therapeutics TTM net income year-on-year change?
What is Seres Therapeutics annual net profit?
The current annual net income of MCRB is -$113.72 M
What is the all time high annual net income for Seres Therapeutics?
Seres Therapeutics all-time high annual net profit is -$3.13 M
What is Seres Therapeutics annual net income year-on-year change?
Over the past year, MCRB annual net profit has changed by +$136.43 M (+54.54%)
What is Seres Therapeutics quarterly net profit?
The current quarterly net income of MCRB is $88.78 M
What is the all time high quarterly net income for Seres Therapeutics?
Seres Therapeutics all-time high quarterly net profit is $88.78 M
What is Seres Therapeutics quarterly net income year-on-year change?
Over the past year, MCRB quarterly net profit has changed by +$130.02 M (+315.22%)
What is Seres Therapeutics TTM net profit?
The current TTM net income of MCRB is -$25.48 M
What is the all time high TTM net income for Seres Therapeutics?
Seres Therapeutics all-time high TTM net profit is -$1.69 M
What is Seres Therapeutics TTM net income year-on-year change?
Over the past year, MCRB TTM net profit has changed by +$88.25 M (+77.60%)